Here are what the editors at HealthDay consider to be the most important developments in Urology for August 2017. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Minimal Evidence for Electronic Communication Guidelines
THURSDAY, Aug. 31, 2017 (HealthDay News) — Minimal evidence is available for guidelines for electronic communication between patients and providers, according to research published online Aug. 28 in the Journal of the American Medical Informatics Association.
CDC: 60 Percent of America’s Single Men Report Using Condoms
THURSDAY, Aug. 31, 2017 (HealthDay News) — About six in 10 sexually active single men in the United States are taking responsibility for birth control, according to an August data brief published by the U.S. Centers for Disease Control and Prevention’s National Center for Health Statistics.
Paternal Age in the United States Is Rising
WEDNESDAY, Aug. 30, 2017 (HealthDay News) — The average age of fathers of newborns has risen in recent decades, raising questions about the possible social and public health impact, according to research published online Aug. 30 in Human Reproduction.
Proactive Approach Encouraged for Online Patient Reviews
WEDNESDAY, Aug. 30, 2017 (HealthDay News) — Most patients are using online reviews as a first step to finding a new doctor, with 65 percent forming an opinion from reading one to six reviews, according to a report published in Medical Economics.
FDA Approves Vabomere for Complicated UTIs
WEDNESDAY, Aug. 30, 2017 (HealthDay News) — The intravenous antibiotic Vabomere (meropenem and vaborbactam) has been approved by the U.S. Food and Drug Administration to treat certain complicated urinary tract infections, including pyelonephritis.
Options Available for Estrogen Depletion After Breast Cancer
TUESDAY, Aug. 29, 2017 (HealthDay News) — Many non-hormone options and therapies are available for the treatment of estrogen-depletion symptoms in breast cancer survivors, and individualized treatment is important, according to a review published online Aug. 2 in the Journal of Clinical Endocrinology & Metabolism.
Estrogen Via Patch Superior for Menopausal Sexual Symptoms
TUESDAY, Aug. 29, 2017 (HealthDay News) — Supplemental estrogens may be beneficial for sexual function in menopausal women, but the form of medication delivery appears to matter, according to a study published online Aug. 28 in JAMA Internal Medicine.
Androgen-Deprivation Therapy May Carry Cardiovascular Risks
MONDAY, Aug. 28, 2017 (HealthDay News) — Use of androgen-deprivation therapy (ADT) may increase the risk of certain cardiovascular conditions in men with prostate cancer, according to a study published online Aug. 24 in the British Journal of Cancer.
Nurse-, System-Related Factors Analyzed in Wrong-Patient Events
WEDNESDAY, Aug. 23, 2017 (HealthDay News) — Greater focus is needed on correct identification processes in order to prevent wrong-patient medication administration incidents, and system supports for nurses are critical, according to a study published online Aug. 17 in the Journal of Clinical Nursing.
Many Parents Would Support Transgender Teen’s Transition
TUESDAY, Aug. 22, 2017 (HealthDay News) — More than half of U.S. adults surveyed would be supportive if they had a teenage child who wanted to transition to the opposite gender, according to a Harris Poll commissioned by the American Osteopathic Association.
Hours Worked Impacted by Kids for Female, Not Male Doctors
MONDAY, Aug. 21, 2017 (HealthDay News) — For women, but not men, in dual-physician couples, weekly hours worked are lower for those with versus those without children, according to a research letter published online Aug. 21 in JAMA Internal Medicine.
Geriatric Consults Remain Rare in Kidney Cancer Care
MONDAY, Aug. 21, 2017 (HealthDay News) — Use of geriatric consultation remains sparse among older patients undergoing surgery for kidney cancer, according to a study published online Aug. 11 in the Journal of the American Geriatrics Society.
Zika Does Not Appear to Last in Semen As Long As Thought
FRIDAY, Aug. 18, 2017 (HealthDay News) — The Zika virus might not remain in the semen of some infected men as long as previously thought, according to a research letter published in the Aug. 17 issue of the New England Journal of Medicine.
Worse Survival Seen for Alternative Vs Usual Cancer Rx
FRIDAY, Aug. 18, 2017 (HealthDay News) — Patients who choose alternative medicine over traditional cancer treatments for curable cancers have a higher risk of dying early, according to research published online Aug. 10 in the Journal of the National Cancer Institute.
Few Racial Differences in Peds Anesthesia Meds Administration
THURSDAY, Aug. 17, 2017 (HealthDay News) — There does not appear to be significant racial differences in preoperative or intraoperative medication administration for children undergoing emergency appendectomies, according to a study published online Aug. 10 in Pediatric Anesthesia.
Studies Used for FDA Approval of Device Changes Often Low Quality
TUESDAY, Aug. 15, 2017 (HealthDay News) — Many studies used to support U.S. Food and Drug Administration approval of high-risk medical device modifications are not controlled; and efficacy of drugs granted accelerated approval is often confirmed three years after approval, according to two studies published in the Aug. 15 issue of the Journal of the American Medical Association.
Specialist Access No Better With Adoption of Access Standards
TUESDAY, Aug. 15, 2017 (HealthDay News) — Adoption of specialty access standards does not improve access to specialists, according to a study published online Aug. 14 in JAMA Internal Medicine.
Graft Survival Similar for Kidneys From Octogenarians
TUESDAY, Aug. 15, 2017 (HealthDay News) — Graft survival is similar for recipients of kidneys from >80-year-old donors and donors aged ≤60 years, according to a study published online Aug. 9 in the American Journal of Transplantation.
Osteoporosis Meds Up BMD in Nonmetastatic Prostate Cancer
MONDAY, Aug. 7, 2017 (HealthDay News) — For men with nonmetastatic prostate cancer who are receiving androgen deprivation therapy (ADT), bisphosphonates and denosumab improve bone mineral density (BMD), according to a review published online Aug. 8 in the Annals of Internal Medicine.
Guidance Provided for Preventing Practice Billing Errors
MONDAY, Aug. 7, 2017 (HealthDay News) — Strategies can help to prevent medical practice billing errors, according to a report published in Medical Economics.
Revenue Exceeds Expenditures for Many ABMS Member Boards
WEDNESDAY, Aug. 2, 2017 (HealthDay News) — Overall revenue exceeds expenditures for many American Board of Medical Specialties (ABMS) member boards, according to a study published in the Aug. 1 issue of the Journal of the American Medical Association.
Copyright © 2017 ScoutNews, LLC. All rights reserved.